Infections caused by toxigenic strains of *Corynebacterium diphtheriae* have become uncommon in Europe as a result of widespread vaccination. Cutaneous diphtheria is endemic in tropical countries but uncommon in Europe. However, sporadic cases still occur, predominantly imported from areas of high endemicity. We report a case of cutaneous infection due to *C diphtheriae* biotype mitis in a young man returning from Senegal to France.

CASE REPORT {#s1}
===========

On September 22, 2015, a 21-year-old man with an unremarkable medical history, returning from Senegal with multiple infected mosquito bites on legs and arms, was admitted to our emergency department. Cutaneous lesions had developed several days after walking barefoot in wetlands in Senegal. Skin examination showed maculopapular ulcerative and crusted lesions on legs ([Figure 1](#F1){ref-type="fig"}) and arms. He received amoxicillin/clavulanate (3 grams per day for 14 days) and was discharged.

![Skin ulceration visible on legs of a patient with cutaneous diphtheria.](ofw27101){#F1}

Leg lesion swabs were cultured on blood agar and chocolate agar (bioMérieux, Marcy-l'Etoile, France). After 24 hours of incubation, abundant growth of small non-hemolytic and β-hemolytic colonies was observed on both media. Rapid identification using matrix-assisted laser desorption-ionization time-of-flight mass spectrometry (\[MALDI-TOF MS\] Microflex LT; Bruker Daltonics) was performed directly on both colony types. *Staphylococcus aureus* and *Streptococcus pyogenes* were identified in the β-hemolytic colonies. In the non-hemolytic colonies, *C diphtheriae* was identified with a score value of 2.243. This isolate was sent to the National Reference Center for *Corynebacteria* of the *diphtheriae* Complex (\[NRC-Cd\] Institut Pasteur, Paris, France). Three days later, the patient was hospitalized in the infectious diseases department without alteration of his general condition, fever, pharyngitis, pseudomembranous angina, cervical adenitis, or clinical evidence of toxemia but with persistent superficial skin ulcerations on both legs. C-reactive protein was 9 mg/L, and leukocyte count was 6200/mm^3^; human immunodeficiency virus status was seronegative, and there was no laboratory evidence of immunosuppression.

On September 25, NRC-Cd confirmed the identification of *C diphtheriae* biovar mitis and polymerase chain reaction analysis revealed the presence of the *tox* gene. The same day, the patient received diphtheria antitoxin because of his unclear vaccination status. Late examination of his vaccination record showed an up-to-date vaccination against diphtheria, as well as his close contacts. A delayed titration of antibodies against diphtheria toxin (\[DT\] before antitoxin administration) revealed a protective level of 3.28 IU/mL, consistent with full serologic protection. The clinical course was favorable with rapid and complete skin ulcer resolution 7 days after beginning antibiotics.

Cultures of an oropharyngeal swab obtained at readmission were negative. Tracing of close contacts of the patient was initiated on admission and 1 physician was identified. He received oral antibiotic prophylaxis. Cultures of his throat swabs were negative.

One week later, Elek's test performed by the NRC-Cd did not reveal toxin secretion. The strain was resistant to fosfomycin, penicillin, and trimethoprim (minimum inhibitory concentrations, \>1024, 0.125, and \>32 mg/L, respectively). Results of molecular typing by multilocus sequence typing (MLST) showed that the strain belonged to ST387. This ST is novel, and no other isolate with this ST has been recorded so far in the MLST database (<http://pubmlst.org/cdiphtheriae/>).

DISCUSSION {#s2}
==========

Cutaneous diphtheria is uncommon in France but not rare in tropical regions \[[@CIT0001]\]. The disease is characterized by shallow skin ulcers that are usually chronic, often after insect bites or minor traumas \[[@CIT0002]\]. The incubation period, on average 2 to 4 days for respiratory tract diphtheria, is not well defined for cutaneous infection \[[@CIT0003]\]. Consistent with previous reports, *C diphtheriae* was found in our patient in association with *S aureus* and *S pyogenes* \[[@CIT0004]\]. Reacher et al \[[@CIT0005]\] found 28% of *C diphtheriae* isolates to be associated with β-hemolytic streptococci. Cutaneous diphtheria in Europe is mainly travel-related \[[@CIT0003], [@CIT0005]\].

Cutaneous diphtheria is usually due to toxigenic *C diphtheriae* producing the *tox* gene-encoded DT, an ADP-ribosyltransferase of 58.35 kDa \[[@CIT0001]\]. The *tox* gene is carried by a corynebacteriophage and regulated by the chromosome-encoded regulator DtxR (DT repressor). Integration of *tox*-carrying bacteriophages into the bacterial genome (lyzogenization) can convert non-toxigenic strains into toxigenic and virulent strains \[[@CIT0006]\].

Non-toxigenic *C diphtheriae* is increasingly recognized as an emerging pathogen across Europe \[[@CIT0007], [@CIT0008]\]. In France, between 2000 and 2010, 44 non-toxigenic isolates were sent to the NRC-Cd. Of the *C diphtheriae* isolates sent to the NRC-Cd, 90% do not carry the *tox* gene \[[@CIT0008]\]. Current French guidelines recommend to considering non-toxigenic *C diphtheriae* as a potential pathogen and to treat infected patients \[[@CIT0008]\]. Infections caused by non-toxigenic *C diphtheriae* are not preventable by vaccination, and pathogenic mechanisms remain unclear \[[@CIT0002]\]. Lowe et al \[[@CIT0004]\] published a 10-year review of 33 cases of cutaneous diphtheria in Canada where all *C diphtheriae* isolates, from wounds, were non-toxigenic. Non-toxigenic *C diphtheriae* usually completely lack the *tox* gene. However, as with the *C diphtheriae* isolate from our studied patient, some rare non-toxigenic strains do bear the *tox* gene but do not express it and are called "non-toxigenic tox gene-bearing" (NTTB) \[[@CIT0006]\]. Groman et al \[[@CIT0009]\] found that 14 of 43 non-toxigenic US isolates carried at least part of the toxin gene (as verified with gene probes). In the United Kingdom, Zakikhany et al \[[@CIT0006]\] identified 5 (4.6%) NTTB isolates, from 4 humans and 1 cat, among 108 non-toxigenic *C diphtheriae* biovar mitis strains. Molecular analysis of NTTB isolates suggested 2 mechanisms causing the blockage of *tox* gene expression, a single base deletion resulting in a frameshift or the insertion of an insertion sequence (IS) element in the gene \[[@CIT0006]\]. Moreover, non-toxigenic strains tend to replace toxigenic strains with widespread vaccination \[[@CIT0010]\]. Simultaneous presence of toxigenic and non-toxigenic bacteria within a same population has even been described by Simmons et al \[[@CIT0011]\]. Because toxigenic and non-toxigenic colonies are indistinguishable in terms of morphology on agar plates, microbiologists should test several colonies (from the primary plate) for toxin production before reporting that a strain is non-toxigenic. In the present case, the possibility of a double population cannot be excluded. The NTTB *C diphtheriae* constitute a *tox* gene reservoir conferring a theoretical risk of re-emerging toxin expression through spontaneous reversion into toxigenic strains or through homologous recombination between different corynebacteriophages \[[@CIT0006]\]. Considering the high pathogenicity and transmissibility of *C diphtheriae*, prompt identification of the pathogen, including NTTB isolates, is of utmost importance. The MALDI-TOF MS was shown to be an accurate and rapid procedure for identification of corynebacteria \[[@CIT0012]\]. Identification of *C diphtheriae* using MALDI-TOF MS should alert the microbiologist and trigger further search for the *tox* gene. Here, detection of *C diphtheriae* allowed rapid initiation of effective antibiotic therapy and protective measures for healthcare workers and other close contacts.

CONCLUSIONS {#s3}
===========

Non-toxigenic strains of *C diphtheriae* are now recognized as emerging pathogens across Europe \[[@CIT0007]\]. In this study, we report a case of cutaneous infection due to an NTTB *C diphtheriae* strain acquired in Senegal. Because of public health implications associated with toxigenic *C diphtheriae*, rapid and reliable identification of *Corynebacterium* species and the research of *tox* gene are mandatory. The MALDI-TOF MS can be applied successfully to identify *C diphtheriae*. This case highlights the importance of support from reference laboratories, which can provide rapidly microbiological results that contribute to prevent the further spread of the pathogen.
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